These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3909371)

  • 1. Fasting plasma C-peptide levels in health and impaired glucose tolerance: relations to blood glucose and relative body weight.
    Birgerstam G; Malmquist J
    Scand J Clin Lab Invest; 1985 Dec; 45(8):707-12. PubMed ID: 3909371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and C-peptide responses to 75 g oral glucose load in the healthy man.
    Bonora E; Zavaroni I; Alpi O; Pezzarossa A; Bruschi F; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
    Diabete Metab; 1986 Jun; 12(3):143-8. PubMed ID: 3525269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia.
    Bonora E; Rizzi C; Lesi C; Berra P; Coscelli C; Butturini U
    Dig Dis Sci; 1988 Jun; 33(6):732-6. PubMed ID: 3286157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus.
    Hovorka R; Chassin L; Luzio SD; Playle R; Owens DR
    J Clin Endocrinol Metab; 1998 Mar; 83(3):744-50. PubMed ID: 9506719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.
    Marita AR; Sarkar JA; Rane S
    Mol Cell Biochem; 2005 Jul; 275(1-2):143-51. PubMed ID: 16335794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
    Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K
    Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
    Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
    Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Williams S; Hayes TM
    Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus.
    Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M
    Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.
    Hosker JP; Rudenski AS; Burnett MA; Matthews DR; Turner RC
    Metabolism; 1989 Aug; 38(8):767-72. PubMed ID: 2668699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
    Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W
    Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.